267 research outputs found
Bridging The Coaching/Therapy Divide: What Co-Active Coaches Can Learn From ACT (Acceptance And Commitment Therapy)
Abstract This paper situates the coaching/therapy divide within the context of new regulations in Ontario, Canada, that limit the use of the term 'psychotherapy,' and the practice of psychotherapy. Taking Co-Active Coaching and Acceptance and Commitment Therapy (ACT) as representative examples of coaching and therapy respectively, I examine each in turn, showing that Co-Active Coaching and ACT, as they are described by their founders, overlap in important ways, to the point they are almost indistinguishable in practice. I conclude that artificially distinguishing between coaching and therapy is unhelpful for therapists and coaches, as well as the client populations they serve
Von der Bewegung fĂŒr "gemeindenahe psychosoziale Versorgung" zum "Krieg den Drogen": eine Studie ĂŒber die Definition sozialer Probleme
Die Studie untersucht die VerĂ€nderungen in der staatlich geförderten gemeindenahen psychosozialen Versorgung in den USA wĂ€hrend der konservativen Regierung der 80er Jahre. Zuvor basierte die Versorgung auf der Ăberzeugung, daĂ psychische Probleme im Kontext der sozialen Lebenswelt entstehen. Nunmehr wurden die Aspekte Eigenverschulden und Strafverfolgung zur Grundlage konservativer Gesundheits- und Drogenpolitik, begleitet von Rassendiskriminierung in der Strafverfolgung. Innerhalb der wissenschaftlichen Forschung wurden AbhĂ€ngige im gehobenen Sozialmilieu ausgewĂ€hlt mit besseren Voraussetzungen fĂŒr Heilungschancen nicht zuletzt aufgrund von finanzieller Belastbarkeit. Dadurch wurde die konservative Sichtweise des Problems begĂŒnstigt. Der Einsatz von Persönlichkeitsfragebögen wird problematisiert und eine stete Selbstreflexion der Forscher gefordert. PrimĂ€r- und SekundĂ€rquellen wurden verwertet. (ICB
Automated compliance checking in healthcare building design
Regulatory frameworks associated to building design are usually complex, representing extensive sets of requirements. For healthcare projects in the UK, this includes statutory and guidance documents. Existing research indicates that they contain subjective requirements, which challenge the practical adoption of automated compliance checking, leading to limited outcomes. This paper aims to propose recommendations for the adoption of automated compliance checking in the design of healthcare buildings. Design Science Research was used to gain a detailed understanding of how information from existing regulatory requirements affects automation, through an empirical study in the design of a primary healthcare facility. In this study, a previously proposed taxonomy was implemented and refined, resulting in the identification of different types of subjective requirements. Based on empirical data emerging from the research, a set of recommendations was proposed focusing on the revision of regulatory documents, as well as to aid designers implementing automated compliance in practice
Versatile spaceborne photonics with chalcogenide phase-change materials
Recent growth in space systems has seen increasing capabilities packed into
smaller and lighter Earth observation and deep space mission spacecraft.
Phase-change materials (PCMs) are nonvolatile, reconfigurable, fast-switching,
and have recently shown a high degree of space radiation tolerance, thereby
making them an attractive materials platform for spaceborne photonics
applications. They promise robust, lightweight, and energy-efficient
reconfigurable optical systems whose functions can be dynamically defined
on-demand and on orbit to deliver enhanced science or mission support in harsh
environments on lean power budgets. This comment aims to discuss the recent
advances in rapidly growing PCM research and its potential to transition from
conventional terrestrial optoelectronics materials platforms to versatile
spaceborne photonic materials platforms for current and next-generation space
and science missions. Materials International Space Station Experiment-14
(MISSE-14) mission-flown PCMs outside of the International Space Station (ISS)
and key results and NASA examples are highlighted to provide strong evidence of
the applicability of spaceborne photonics.Comment: 16 pages, 4 figure
Versatile spaceborne photonics with chalcogenide phase-change materials.
This is the final version. Available on open access from Nature Research via the DOI in this record.âŻData availability: The data that support the findings of this study are available from the corresponding author upon reasonable request.Recent growth in space systems has seen increasing capabilities packed into smaller and lighter Earth observation and deep space mission spacecraft. Phase-change materials (PCMs) are nonvolatile, reconfigurable, fast-switching, and have recently shown a high degree of space radiation tolerance, thereby making them an attractive materials platform for spaceborne photonics applications. They promise robust, lightweight, and energy-efficient reconfigurable optical systems whose functions can be dynamically defined on-demand and on-orbit to deliver enhanced science or mission support in harsh environments on lean power budgets. This comment aims to discuss the recent advances in rapidly growing PCM research and its potential to transition from conventional terrestrial optoelectronics materials platforms to versatile spaceborne photonic materials platforms for current and next-generation space and science missions. Materials International Space Station Experiment-14 (MISSE-14) mission-flown PCMs outside of the International Space Station (ISS) and key results and NASA examples are highlighted to provide strong evidence of the applicability of spaceborne photonics
Collecting wild Miscanthus germplasm in Asia for crop improvement and conservation in Europe whilst adhering to the guidelines of the United Nationsâ Convention on Biological Diversity
We would like to thank Dr Helen Ougham and Professor Howard Thomas for their valuable comments on this manuscript; Sarah Hawkins at IBERS for the leading of harvesting and phenotyping works; and Paul Barber at Plant Health and Seeds Inspectorate, Wales & West Midlands, Animal and Plant Health Agency (APHA) for advice on germplasm collection practice and quarantine management. This research was supported by the UKâs Department for Environment, Food and Rural Affairs (Defra) under a project entitled âAccession of CBD compliant Miscanthus and Triarrhena germplasm from China, Japan and Taiwan for incorporation in the UK Miscanthus breeding programmeâ [grant no. NF0436]. The breeding and evaluation were conducted under âGenetic improvement of Miscanthus as a sustainable feedstock for bioenergy in the UK (GIANT)â [supported by Defra and the Biotechnology and Biological Sciences Research Council (BBSRC http://dx.doi.org/10.13039/501100000690, âResearch Councils UKâ), UK, grant no. LK0863]. LH, ID and JCB were supported by BBSRC grant nos BBS/E/G/00003134 and BBS/E/W/0012843A.Peer reviewedPublisher PD
Recommended from our members
Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.
GWAS have identified a breast cancer susceptibility locus on 2q35. Here we report the fine mapping of this locus using data from 101,943 subjects from 50 case-control studies. We genotype 276 SNPs using the 'iCOGS' genotyping array and impute genotypes for a further 1,284 using 1000 Genomes Project data. All but two, strongly correlated SNPs (rs4442975 G/T and rs6721996 G/A) are excluded as candidate causal variants at odds against >100:1. The best functional candidate, rs4442975, is associated with oestrogen receptor positive (ER+) disease with an odds ratio (OR) in Europeans of 0.85 (95% confidence interval=0.84-0.87; P=1.7 Ă 10(-43)) per t-allele. This SNP flanks a transcriptional enhancer that physically interacts with the promoter of IGFBP5 (encoding insulin-like growth factor-binding protein 5) and displays allele-specific gene expression, FOXA1 binding and chromatin looping. Evidence suggests that the g-allele confers increased breast cancer susceptibility through relative downregulation of IGFBP5, a gene with known roles in breast cell biology
- âŠ